Clinical trial
Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy…
NCT00385710 · Nantes University Hospital, Other · Completed
Key facts
| NCT number | NCT00385710 |
|---|---|
| Title | Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine) |
| Official title | Randomized Placebo-controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Progressive Supranuclear Palsy |
| Intervention type | Drug |
| Interventions | valproic acid, Placebo |
| Enrollment | 28 |
| Start date | Nov 1, 2006 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Oct 11, 2006 |
| Last update posted | Nov 5, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: